SEC Form D · filed February 16, 2021
Shoreline Biosciences, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (14)
Steven G. Holtzman · San Diego, CADirectorMarios G. Fotiadis · San Diego, CADirectorChristopher S. Fuglesang · San Diego, CADirectorDan S. Kaufman · San Diego, CADirectorDavid W. Scalzo · Daytona Beach, FLDirectorJohn W. Lobdell · Daytona Beach, FLDirectorTrevor W. Perrott · Daytona Beach, FLDirectorThomas Bailey · HOBE SOUND, FLDirectorKleanthis G. Xanthopoulos, Ph.D · La Jolla, CAExec · DirectorJeffrey L. Ives · Newton Centre, MADirectorJustin L. Burns · Newton Centre, MADirectorMartin Jefson · Newton Centre, MADirectorAlexandra A. Clegg · Warwick, RIDirectorKleanthis G. Xanthopoulos, Ph.D · La Jolla, CAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗